Currently out of the existing stock ratings of Vernon Bernardino, 153 are a BUY (94.44%), 9 are a HOLD (5.56%).

Vernon Bernardino

Work Performance Price Targets & Ratings Chart

Analyst Vernon Bernardino, currently employed carries an average stock price target met ratio of 37.26% that have a potential upside of 70.91% achieved within 173 days. Previously, Vernon Bernardino worked at HC WAINWRIGHT.

Vernon Bernardino’s has documented 288 price targets and ratings displayed on 29 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on NVAX, Novavax at 10-Dec-2024.

Wall Street Analyst Vernon Bernardino

Analyst best performing recommendations are on CTXR (CITIUS PHARMACEUTICALS).
The best stock recommendation documented was for CTXR (CITIUS PHARMACEUTICALS) at 11/12/2024. The price target of $4 was fulfilled within 14 days with a profit of $3.5 (700%) receiving and performance score of 500.

Average potential price target upside

of $32.12 (119.71%) on NVAX (NOVAVAX).
of $21.73 (269.37%) on AVEO (AVEO PHARMACEUTICALS).
of $18.9 (94.46%) on SAVA (CASSAVA SCIENCES).

CVM CEL-SCI Corp NVAX Novavax RMED RA Medical Systems AIKI Aikido Pharma ARTL Artelo Biosciences AYTU Aytu BioScience DYAI Dyadic International ELDN Eledon Pharmaceuticals CYTK Cytokinetics MCRB Seres Therapeutics GOVX GeoVax Labs ABEO Abeona Therapeutics AVEO AVEO Pharmaceuticals CTXR Citius Pharmaceuticals EDSA Edesa Biotech GALT Galectin Therapeutics GMDA Gamida Cell Ltd NDRA ENDRA Life Sciences NRXP NRX Pharmaceuticals SAVA Cassava Sciences ACER Acer Therapeutics ARDS Aridis Pharmaceuticals CANF Can Fite Biopharma Ltd ADR FNCH Finch Therapeutics Group SENS Senseonics Holdings TFFP Tff Pharmaceuticals AEMD Aethlon Medical NVCN Neovasc EVOK Evoke Pharma

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Vernon Bernardino (HCWAINWRIGHT)

Buy

$23

$20.48 (812.70%)

$23

4 years 5 months 23 days ago
(29-Jun-2020)

3/3 (100%)

$7.84 (62.73%)

284

Please subscribe to see the analyst performance score

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Vernon Bernardino is most bullish on?

Potential upside of $113.65 has been obtained for SAVA (CASSAVA SCIENCES)

Which stock is Vernon Bernardino is most reserved on?

Potential downside of $1.4 has been obtained for CTXR (CITIUS PHARMACEUTICALS)

What Year was the first public recommendation made by Vernon Bernardino?

On 2015